Meta-Analysis of the Efficacy of Adjunctive NMDA Receptor Modulators in Chronic Schizophrenia

2011/10/01 by Surendra P. Singh, Surendra Prasad Singh, Vidhi Singh · 173 citations
Biochemistry, Genetics and Molecular Biology · Medicine · Neuroscience · #Amino Acid Enzymes and Metabolism #Clinical trial #Cochrane Library #Internal medicine #Medicine #Meta-analysis #Neuroscience and Neuropharmacology Research #Pathology #Placebo #Psychiatry #Randomized controlled trial #Schizophrenia (object-oriented programming) #Strictly standardized mean difference #Tryptophan and brain disorders

paper · doi:10.2165/11586650-000000000-00000

published in CNS Drugs 25(10), 859-885 (Springer Science and Business Media LLC)

crossref issued 2011/10/01 · crossref published 2011/10/01 · crossref published-print 2011/10/01 · openalex publication_date 2011/10/01 · crossref created 2011/10/04 · crossref deposited 2024/04/13 · openalex created_date 2025/10/10 · crossref indexed 2026/06/20 · openalex updated_date 2026/07/29

Citations

• Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans
• Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology
• Attenuation of the Neuropsychiatric Effects of Ketamine With Lamotrigine
• A meta-analysis of outcome studies comparing bona fide psychotherapies: Empiricially, "all must have prizes."
• Statistical power analysis for the behavioral sciences
• Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration

Cited by

• D-Serine: Potential Therapeutic Agent and/or Biomarker in Schizophrenia and Depression?
• Serine [wikipedia]